Health Grant List
Week of September 20, 2010
1.
SUID/SIDS Prevention and Bereavement Support Resource Centers
Health Resources & Services Administration
Deadline: October 25, 2010
2.
NHLBI Program Project Applications (P01)
National Institutes of Health
Deadline: September 7, 2013
3.
Cancer Diagnostic and Therapeutic Agents Enabled by Nanotechnology (SBIR
[U43/U44])
National Institutes of Health
Deadline: July 8, 2013
-------------------------------------------------------------------------------------------------1.
SUID/SIDS Prevention and Bereavement Support Resource Centers
Health Resources & Services Administration
Deadline: October 25, 2010
Document Type: Modification to Previous Grants Notice
Funding Opportunity Number: HRSA-11-104
Opportunity Category: Discretionary
Posted Date: Sep 22, 2010
Creation Date: Sep 22, 2010
Original Closing Date for Applications: Oct 25, 2010
Current Closing Date for Applications: Oct 25, 2010
Archive Date: Dec 23, 2010
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 3
Estimated Total Program Funding: $455,000
Award Ceiling:
Award Floor:
CFDA Number(s): 93.110 -- Maternal and Child Health Federal Consolidated Programs
Cost Sharing or Matching Requirement: No
Eligible Applicants
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility:
C:\Documents and Settings\boothnm\Desktop\Michigan Stuff\OU\Health Grant List\2010\Health Grant List 9.20.10.doc
As cited in Title 42 of the Code of Federal Regulations Part 51a.3(a), any public or private entity,
including an Indian tribe or tribal organization (as those terms are defined at 25 U.S.C. 450b) is
eligible to apply for this Federal funding. As cited in Title 42 of the Code of Federal Regulations
Part 51a.3(a), any public or private entity, including an Indian tribe or tribal organization (as
those terms are defined at 25 U.S.C. 450b) is eligible to apply for this Federal funding.
Agency Name
Health Resources & Services Administration
Description
The purpose of the Sudden and Unexpected Infant Death/Sudden Infant Death Syndrome
(SUID/SIDS) Cooperative Agreement Program is to meet the needs of families and others that
are impacted by the tragedy of (SIDS/ID) and provide a mechanism for communication and
collaboration among the State SIDS/ID programs, associated groups, organizations, and
Maternal and Child Health Bureau (MCHB) staff to assure improved infant health status through
improved health care systems.
Link to Full Announcement
https://grants.hrsa.gov/webExternal/SFO.asp?ID=899897E0-CF31-4612-8281-C02F0B38985B
--------------------------------------------------------------------------------------------2.
NHLBI Program Project Applications (P01)
National Institutes of Health
Deadline: September 7, 2013
Document Type: Grants Notice
Funding Opportunity Number: PAR-10-285
Opportunity Category: Discretionary
Posted Date: Sep 21, 2010
Creation Date: Sep 21, 2010
Original Closing Date for Applications: Sep 07, 2013
Current Closing Date for Applications: Sep 07, 2013
Archive Date: Oct 08, 2013
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Estimated Total Program Funding: $1,515,000
Award Ceiling:
Award Floor:
CFDA Number(s): 93.233 -- National Center on Sleep Disorders Research
93.837 -- Cardiovascular Diseases Research
93.838 -- Lung Diseases Research
93.839 -- Blood Diseases and Resources Research
Cost Sharing or Matching Requirement: No
-2-
Eligible Applicants
State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher
education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving
Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based
Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities
(HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized);
Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory
or Possession.
Agency Name
National Institutes of Health
Description
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Heart, Lung,
and Blood Institute (NHLBI) continues the long standing program project program detailed at
http://www.nhlbi.nih.gov/funding/resmech.htm and invites submission of investigator-initiated
Program Project (P01) applications. The proposed programs may address scientific areas relevant
to the NHLBI mission including the biology and diseases of the heart, blood vessels, lung, and
blood; blood resources; and sleep disorders. Each P01 application submitted in response to this
FOA must include at least three related research projects that share a common central theme,
focus, and/or overall objective. Mechanism of Support. This FOA will utilize the NIH Program
Project (P01) grant mechanism. Funds Available and Anticipated Number of Awards. The total
amount awarded and the number of awards will depend upon the numbers, quality, duration, and
costs of the applications received.
Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-10-285.html
----------------------------------------------------------------------------------------
-3-
3.
Cancer Diagnostic and Therapeutic Agents Enabled by Nanotechnology (SBIR
[U43/U44])
National Institutes of Health
Deadline: July 8, 2013
Document Type: Grants Notice
Funding Opportunity Number: PAR-10-286
Opportunity Category: Discretionary
Posted Date: Sep 21, 2010
Creation Date: Sep 21, 2010
Original Closing Date for Applications: Jul 08, 2013
Current Closing Date for Applications: Jul 08, 2013
Archive Date: Aug 08, 2013
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Estimated Total Program Funding:
Award Ceiling: $150,000
Award Floor:
CFDA Number(s): 93.393 -- Cancer Cause and Prevention Research
93.394 -- Cancer Detection and Diagnosis Research
93.395 -- Cancer Treatment Research
93.396 -- Cancer Biology Research
Cost Sharing or Matching Requirement: No
Eligible Applicants
Small businesses
Additional Information on Eligibility:
Agency Name
National Institutes of Health
Description
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer
Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research
(SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to
develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and
in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of
these cancer-relevant nanotechnology applications against the intended cancer type. The
proposed projects must be milestone-driven and must be clearly directed toward development of
an ultimate commercial product. The outcomes are expected to advance the discovery and pre-
-4-
clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device
Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA)
by the end or shortly after completion of the Phase II project period. To facilitate these steps, the
NCI will assist the awardees in various ways, including the support through the NCI-sponsored
Nanotechnology Characterization Laboratory. This FOA will NOT support basic research
projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA
will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II
applications. Funds Available and Anticipated Number of Awards. Awards issued under this
FOA are contingent upon the availability of funds and the submission of a sufficient number of
meritorious applications. The total amount awarded and the number of awards will depend upon
the quality, duration, and costs of the applications received.
Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-10-286.html
-5-